🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

SBRT + 💊 in oligomets: 🧍‍♂️2294 pts | 🫁, breast, prostate, colorectal ⚠️Grade 3+ AEs: 1.5% ✅ SBRT Safe with systemic tx! #SBRT #OligoCare #ESTRO25 EORTC ESTRO Ciro Franzese

Can liquid biopsy guide treatment in oligorecurrent #Pca? In #RADIOSA we explored if a mutational signature in cfDNA predicts outcomes: - HR mutations (BRCA1/2, ATM, TP53, etc.) = ↓PFS - 19 mo vs 35 mo without HRM Liquid biopsy may help identify pts needing > intense treatment

🚀🔥⚡️ Honored to be part of PEACE V-STORM, just published in The Lancet Oncology! MDT vs ENRT in oligorecurrent nodal prostate cancer — a key step forward. Presented at #ESTRO25. #ProstateCancer #STORM #OncoTwitter #Radiotherapy #MDT #ENRT

An honor to moderate this session featuring Late-Breaking papers: 🌟PORTEC-4a 🌟PEACE V – STORM 🌟First RAPID-RT analysis Many compliments to the speakers and discussants! #ESTRO2025

Radoncs need to be more represented when cancer is the topic and radiation therapy is object of discussion for patients. The multidisciplinary approach works when every cancer specialist can be a part of the decision. And radiation therapy is significant in most of guidelines.

Metastasis-directed therapy improves outcomes in oligometastatic #ProstateCancer in #WOLVERINE study. Chad Tang, MD MD Anderson Cancer Center sits down with Leslie Ballas Cedars-Sinai to discuss a meta-analysis of STOMP, ORIOLE, ARTO, EXTEND & COMET-SABR trials on oligometastatic

¡Con muchísima alegría recibimos hoy a la Prof prof. Barbara Jereczek-Fossa 😍👩‍⚕️, presidenta de ESTRO 🌍! Compartimos con ella nuestro flujo de trabajo 🧬🔬 y reforzamos nuestro compromiso con la participación española 🇪🇸🤝 en la sociedad europea ✨🌍. ¡Gracias por inspirarnos! 🙌📚👩‍🔬

It’s the team, not the beam 😊 Matthias Guckenberger ESTRO

🚨 Last chance! Early registration for the Basic Clinical Radiobiology course ends TOMORROW. 📅 7–11 Sept 2025 | 📍 Rome & Online Ideal for trainees, radiation oncologists (CME!), biologists, physicists & RTTs. Secure your spot now 👉 bit.ly/4mturx7 #ESTROSchool25

Eagerly awaiting the next #APCCC Advanced Prostate Cancer Consensus Conference OncoAlert

Must be.

🧠 Survey: #Reirradiation in Primary #BrainTumours Help the ESTRO #CNS Focus Group map current practices across Europe and shape future guidelines. 📅 Deadline: 4 July ✅ Take the survey: bit.ly/3G0pFXg #radonc

The first ever World RT Day is fast approaching - don’t miss out on this opportunity to get involved and support the international awareness campaign for Radiation Therapy! Register at worldradiotherapy.org for updates #WRAD #WorldRTDay Sandra Turner Lucinda Morris

Happy to share that we successfully hosted the very 1st Best of ESTRO in Turkiye, bringing together 150 RO pros for an inspiring day of cutting-edge science. Thanks to our Turkish ROs whose hard work made this possible—and to @ESTRO for launching this initiative. Turkish Society For Radiation Oncology

Practical Recommendations for the Management of Radiodermatitis, on behalf of the ESTRO RTT committee, published in Radiation Oncology. 👉 Read it before your patients: bit.ly/3Fpl9kW BMC

🎉 Congratulazioni ad Antonio Marra per aver vinto il prestigioso grant Next Generation AIRC! Un traguardo straordinario che lo consacra tra gli oncologi del futuro. Si cura meglio solo se si fa ricerca Avanti così, Antonio! 💪🔬 Università degli Studi di Milano IEO #NextGenAIRC

Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C) thelancet.com/journals/lanon… The phase 3 PACE-C trial compared early toxicity between moderately hypofractionated radiotherapy (MHRT) and stereotactic body

📢 Join an ESTRO Focus Group! ✅ Apply now to become a Full Member of one of our Focus Groups: 🔹Imaging 🔹 Oligometastatic Disease 🔹 Children & TYA 🔹Haemato-Oncology ➡️ Contribute to clinical guidelines, scientific programmes, education, and more. ℹ️ bit.ly/4nHXWMj

A warm invite to the Advanced Prostate Cancer Consensus Conference #APCCC26 in Lugano🇨🇭 👉REGISTER HERE: apccc.org/apccc-2026/ In an era of rapid innovation and expanding treatment options for advanced #ProstateCancer , APCCC provides a vital forum for clinicians and

Repositioning #RadiationOncology at the centre of integrated oncology care, a manifesto from ESTRO just published in Radiotherapy & Oncology. 👉 Read the editorial: bit.ly/4lWDg14 #radonc Icro Meattini